Topical resiquimod effective for early-stage cutaneous T-cell lymphomaSeptember 24, 2015MelanomaLymphoma & Plasma Cell Disorders
New cancer cases to reach nearly 2.4 million in 2035 – AACRSeptember 16, 2015Preventive CareLung CancerGynecologic CancerMelanoma
Immune-related patterns of response present challengesAugust 18, 2015Lung CancerMelanomaPatient & Survivor Care
Ipilimumab’s immune-related adverse effects greater in ‘real-world patients’August 17, 2015MelanomaPatient & Survivor Care
Melanoma twice as likely after CLL/SLL than other types of NHLAugust 3, 2015Lymphoma & Plasma Cell DisordersMelanomaPatient & Survivor Care
FDA approves hedgehog pathway inhibitor for locally advanced BCCJuly 24, 2015MelanomaNonmelanoma Skin Cancer
Amlodipine reduced vismodegib-induced muscle crampsJuly 23, 2015Patient & Survivor CareMelanomaNonmelanoma Skin Cancer
